Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Natural Resources, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Email me when HR 9682 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HR 9682. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill directs the Secretary of Health and Human Services to create a national program that purchases hepatitis C antiviral drugs and provides them at no cost to patients, including those in prisons, Indian health facilities, and Medicaid/CHIP populations. It also eliminates Medicare cost‑sharing for these drugs and funds the effort with $5.5 billion over seven years. The goal is to eradicate hepatitis C in the United States.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HR 9682
3 free questions a day, no accountSponsors
- Rep. Miller-Meeks, Mariannette [R-IA-1] (R) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HR 9682 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HR 9682 freeOr ask your AI assistant about HR 9682 directly:
Add to Claude, ChatGPT or Cursor